R&D Systems™ Recombinant Human PSG1 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human PSG1 Protein is derived from NS0. The Recombinant Human PSG1 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P11464
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with trehalose.
• Gene ID (Entrez): 5669
• Molecular Weight (g/mol): 44kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human PSG1 protein Gln35-Pro419,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 2 weeks, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10EU per 1μg of the protein by the LAL method.
• Gene Alias: B1G1, B1G1CD66 antigen-like family member F, CD66f, CD66f antigen, DHFRP2, Fetal liver non-specific cross-reactive antigen 1/2, FLJ90598, FLJ90654, FL-NCA-1/2, PBG1, pregnancy specific beta-1-glycoprotein 1, pregnancy-specific B-1 glycoprotein, Pregnancy-specific beta-1 glycoprotein C/D, pregnancy-specific beta-1-glycoprotein 1, Pregnancy-specific glycoprotein 1, PS-beta-C/D, PS-beta-G-1, PSbG1, PSBG-1, PSBG1SP1, PSG1, PSG95, PSGGA, PSGGAPSG95, PSGIIA
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500μg/mL in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.